Non-metastatic Castration-resistant Prostate Cancer Clinical Trials

9 clinical trials for Non-metastatic Castration-resistant Prostate Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea — RECRUITING
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) — RECRUITING · PHASE4
PROCARE - PROstate Cancer Real World Evidence Registry — RECRUITING
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment — NOT_YET_RECRUITING
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) — COMPLETED · PHASE1
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE1
An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World Settings — COMPLETED
An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States — COMPLETED
An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings — COMPLETED

Refine this search